Company profile for B.More

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

B.More is named after Brett Moore, who died of a drug overdose 50 years ago and was the brother of our co-founder, Claudia Turnbull. To keep his name alive and help others suffering from substance use disorders, B.More came into being. B.More is a 501(c)(3) non-profit lifescience company studying psilocybin, a classic psychedelic, to treat patients suffering from Alcohol Use Disorder (AUD) and who may have been unsuccessful...
B.More is named after Brett Moore, who died of a drug overdose 50 years ago and was the brother of our co-founder, Claudia Turnbull. To keep his name alive and help others suffering from substance use disorders, B.More came into being. B.More is a 501(c)(3) non-profit lifescience company studying psilocybin, a classic psychedelic, to treat patients suffering from Alcohol Use Disorder (AUD) and who may have been unsuccessful with more traditional drug and treatment programs

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
7939 Honeygo Blvd Ste 123, Nottingham, Maryland, 21236, United States
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

34th NZW-Hamburg

Not Confirmed

envelop Contact Supplier

34th NZW-Hamburg

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/bmore-collaborator-dr-michael-bogenschutz-awarded-15-million-nida-grant-for-landmark-psilocybin-study-in-opioid-use-disorder-302287350.html

PR NEWSWIRE
31 Oct 2024

https://www.prnewswire.com/news-releases/bmore-receives-fda-investigational-new-drug-approval-for-psilocybin-alcohol-use-disorder-program-phase-2b-clinical-trial-301609924.html

PRNEWSWIRE
25 Aug 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty